These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5139221)

  • 21. Symbiotic approach to drug design: antihypertensive beta-adrenergic blocking agents.
    Baldwin JJ; Lumma WC; Lundell GF; Ponticello GS; Raab AW; Engelhardt EL; Hirschmann R; Sweet CS; Scriabine A
    J Med Chem; 1979 Nov; 22(11):1284-90. PubMed ID: 42797
    [No Abstract]   [Full Text] [Related]  

  • 22. Amidines and related compounds. 6. Studies on structure-activity relationships of antihypertensive and antisecretory agents related to clonidine.
    Jen T; Van Hoeven H; Groves W; McLean R; Loev B
    J Med Chem; 1975 Jan; 18(1):90-9. PubMed ID: 234014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Synthesis and antihypertensive activity of quinazolinone derivatives].
    Liu KC; Hsu LY
    Arch Pharm (Weinheim); 1985 Jun; 318(6):502-5. PubMed ID: 4026544
    [No Abstract]   [Full Text] [Related]  

  • 24. Guanidine-annelated heterocycles, VII. Synthesis and antihypertensive activity of 2,10-dimethyl-5H,10H-1,2,4-triazolo [5,1-b]quinazolin-5-one.
    Liu KC; Hu MK
    Arch Pharm (Weinheim); 1986 Feb; 319(2):188-9. PubMed ID: 3707300
    [No Abstract]   [Full Text] [Related]  

  • 25. Synthesis and pharmacological evaluation of some new imidazoles.
    Burak K
    Pharmazie; 1991 Sep; 46(9):668-70. PubMed ID: 1798733
    [No Abstract]   [Full Text] [Related]  

  • 26. Synthesis and study of hypotensive activity of naphthylalkyl guanidines and naphthylalkyl 2-aminoimidazoles.
    Donetti A; Omodei-Salè A; Gamba A; Mantegani A
    Farmaco Sci; 1973 Oct; 28(10):784-90. PubMed ID: 4747123
    [No Abstract]   [Full Text] [Related]  

  • 27. Synthesis of potential antihypertensive compounds: N-(4,5-dihydroimidazol-2-yl-amino)pyrroles.
    Trani A; Bellasio E
    Farmaco Sci; 1983 Dec; 38(12):940-9. PubMed ID: 6667740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antihypertensive pyrrolo[1,2-c]quinazolines and pyrrolo[1,2-c]quinazolinones.
    Bandurco VT; Wong EM; Levine SD; Hajos ZG
    J Med Chem; 1981 Dec; 24(12):1455-60. PubMed ID: 7310823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of structural changes in the imidazolidine ring of clonidine on hypotensive activity.
    Timmermans PB; Van Zwieten PA
    Pharmacology; 1978; 16(2):106-14. PubMed ID: 201948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclic guanidines. 17. Novel (N-substituted amino)imidazo[2,1-b]quinazolin-2 ones: water-soluble platelet aggregation inhibitors.
    Ishikawa F; Saegusa J; Inamura K; Sakuma K; Ashida S
    J Med Chem; 1985 Oct; 28(10):1387-93. PubMed ID: 4045917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New 2-aryliminoimidazolidines. I. Synthesis and antihypertensive properties of 2-(2-phenoxyphenylimino)imidazolidines and related compounds.
    Matsuo M; Taniguchi K; Katsura Y; Kamitani T; Ueda I
    Chem Pharm Bull (Tokyo); 1985 Oct; 33(10):4409-21. PubMed ID: 4092269
    [No Abstract]   [Full Text] [Related]  

  • 32. Synthesis of 1- and 3-(1-substituted 4-piperidinyl)-1,2,3,4-tetrahydro-2-oxoquinazolines as potential antihypertensive agents.
    Takai H; Obase H; Nakamizo N; Teranishi M; Kubo K; Shuto K; Kasuya Y; Shigenobu K; Hashikami M; Karashima N
    Chem Pharm Bull (Tokyo); 1985 Mar; 33(3):1116-28. PubMed ID: 4028294
    [No Abstract]   [Full Text] [Related]  

  • 33. The cardiovascular effects of trimazosin.
    Constantine JW; Hess HJ
    Eur J Pharmacol; 1981 Sep; 74(2-3):227-38. PubMed ID: 6120084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on quinazolines and 1,2,4-benzothiadiazine 1,1-dioxides. 8.1, 2 synthesis and pharmacological evaluation of tricyclic fused quinazolines and 1,2,4-benzothiadiazine 1,1-dioxides as potential alpha1-adrenoceptor antagonists.
    Chern JW; Tao PL; Wang KC; Gutcait A; Liu SW; Yen MH; Chien SL; Rong JK
    J Med Chem; 1998 Aug; 41(17):3128-41. PubMed ID: 9703460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. General pharmacology of the novel centrally acting antihypertensive agent moxonidine.
    Armah BI; Hofferber E; Stenzel W
    Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tiamenidine (Hoe 440), a new antihypertensive substance.
    Lindner E; Kaiser J
    Arch Int Pharmacodyn Ther; 1974 Oct; 211(2):305-25. PubMed ID: 4460920
    [No Abstract]   [Full Text] [Related]  

  • 37. 6-Substituted 5-chloro-1,3-dihydro-2H-imidazo(4,5-b)pyrazin-2-ones with hypotensive activity.
    Jones JH; Holtz WJ; Cragoe EJ
    J Med Chem; 1973 May; 16(5):537-42. PubMed ID: 4352334
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pharmacological effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride, a new, antihypertensive substance].
    Hoefke W; Kobinger W
    Arzneimittelforschung; 1966 Aug; 16(8):1038-50. PubMed ID: 6014885
    [No Abstract]   [Full Text] [Related]  

  • 39. Amidines. 3. Thioureas possessing antihypertensive activity.
    Loev B; Bender PE; Bowman H; Helt A; McLean R; Jen T
    J Med Chem; 1972 Oct; 15(10):1024-7. PubMed ID: 5069768
    [No Abstract]   [Full Text] [Related]  

  • 40. [A new antihypertensive agent of the fused pseudothiourea series: naphtho [1,2-d]thiazolo [3,2-a]-2-imidazoline].
    Liu KC; Shih CY; Tuan JY; Chen SF
    Arch Pharm (Weinheim); 1978 Mar; 311(3):267-9. PubMed ID: 655795
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.